FAP and gastric neoplasm: FAPI tracers, including [68Ga]Ga-FAPI-04, specifically bind to FAP and offer significantly improved tumour-to-background ratios compared to FDG in malignancies that are typically FDG-avid, such as pancreatic and gastric tumours.